CAR T-cell therapy for multiple myeloma: state of the art and prospects - The Lancet Haematology
Prevalence of smoldering multiple myeloma based on nationwide screening | Nature Medicine
Diagnostics | Free Full-Text | The Current Role of the Heavy/Light Chain Assay in the Diagnosis, Prognosis and Monitoring of Multiple Myeloma: An Evidence-Based Approach
What Is Multiple Myeloma and How Can It Be Managed?
Multiple myeloma | Nature Reviews Disease Primers
Multiple Myeloma: Symptoms, What It Is, Prognosis & Treatment
Prevalence and Monitoring of Oligosecretory Myeloma | NEJM
CAR T-cell immunotherapy & Stem Cells for Multiple Myeloma
Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up† - Annals of Oncology
Association of patient activity bio-profiles with health-related quality of life in patients with newly diagnosed multiple myeloma: a prospective observational cohort study - eClinicalMedicine
Current Oncology | Free Full-Text | Management of Multiple Myeloma: A Review for General Practitioners in Oncology
Multiple myeloma - The Lancet
The Right Biomarker Strategy to Support Multiple Myeloma Emerging Therapies | CellCarta
Liquid biopsy by analysis of circulating myeloma cells and cell-free nucleic acids: a novel noninvasive approach of disease evaluation in multiple myeloma | Biomarker Research | Full Text
Monitoring Multiple Myeloma - Navigating Care
Understanding CAR T Therapy for the Treatment of Multiple Myeloma
Multiple Myeloma for the Primary Care Provider: A Practical Review to Promote Earlier Diagnosis Among Diverse Populations - The American Journal of Medicine
New Insights into the diagnosis, prognosis and monitoring of Multiple Myeloma: What's the role of the Heavy/Light Chain Assay? | Immunopaedia
The Mutational Landscape of Circulating Tumor Cells in Multiple Myeloma: Cell Reports
Cells | Free Full-Text | Genetic Abnormalities in Multiple Myeloma: Prognostic and Therapeutic Implications
Frontiers | Risk Stratification Before and During Treatment in Newly Diagnosed Multiple Myeloma: From Clinical Trials to the Real-World Setting
A 71 Year Old Woman with Multiple Myeloma Status after Stem Cell Transplantation | myADLM.org
New Insights into the diagnosis, prognosis and monitoring of Multiple Myeloma: What's the role of the Heavy/Light Chain Assay? | Immunopaedia
Multiple Myeloma - Physiopedia
